Evaluation of the Aptima HBV Quant Assay Compared to Abbott RealTime M2000 HBV Quant Assay and Procleix Ultrio Plus dHBV Assay in Plasma Samples

Ying Yan,Le Chang,Huimin Ji,Yang Han,Lunan Wang
DOI: https://doi.org/10.1128/spectrum.01761-22
IF: 3.7
2022-07-27
Microbiology Spectrum
Abstract:The Aptima HBV Quant assay (Hologic Inc., San Diego, CA, USA) is a dual-target real-time transcription-mediated amplification (RT-TMA) assay. This study aims to evaluate whether this assay is suitable for HBV DNA detection.
microbiology
What problem does this paper attempt to address?